In the Media

News From Columbia Law
In the Media

Find an In the Media Item

Search by Title

Search by Faculty Member Featured

Search by Publisher

Search by Area of Study

Start

End

Topic

Searching by

Christopher Morten

September 13, 2023 STAT

In New Regeneron Deal for COVID Drug, White House Imposes Price Limits for First Time

Areas of Study: Administrative Law and Public Policy
Topics: Christopher Morten

Featured Faculty: Christopher Morten Associate Clinical Professor of Law

August 09, 2023 STAT

Public Pharma Is the Best Solution to the Ongoing Problem of Drug Shortages

Areas of Study: Administrative Law and Public Policy; Intellectual Property and Technology
Topics: Homepage; Christopher Morten

Featured Faculty: Christopher Morten Associate Clinical Professor of Law

July 24, 2023 KCBS Radio

Gilead Has Been Accused of Delaying Development of Important HIV Drugs

Areas of Study: Intellectual Property and Technology
Topics: Christopher Morten

Featured Faculty: Christopher Morten Associate Clinical Professor of Law

July 22, 2023 The New York Times

How a Drugmaker Profited by Slow-Walking a Promising H.I.V. Therapy

Areas of Study: Intellectual Property and Technology
Topics: Christopher Morten

Featured Faculty: Christopher Morten Associate Clinical Professor of Law

June 02, 2023 Bloomberg Law

U.S. Urged to Engage HIV Patients in Gilead Drug Royalties Clash

Areas of Study: Intellectual Property and Technology
Topics: Christopher Morten

Featured Faculty: Christopher Morten Associate Clinical Professor of Law

May 31, 2023 Fierce Pharma

U.S. Appeal in High-Stakes Gilead Patent Case Garners Support From Patient Advocates

Areas of Study: Constitutional Law; Intellectual Property and Technology
Topics: Christopher Morten; Clinics; Science, Health, and Information Clinic

Featured Faculty: Christopher Morten Associate Clinical Professor of Law

May 02, 2023 STAT

A Battle Between Gilead and the U.S. Government Over Patents on HIV Prevention Pills Goes to Trial

Areas of Study: Constitutional Law; Intellectual Property and Technology
Topics: Christopher Morten

Featured Faculty: Christopher Morten Associate Clinical Professor of Law

May 02, 2023 Bloomberg Law

Gilead, U.S. Clash in Billion-Dollar Trial on HIV-Drug Patent

Areas of Study: Constitutional Law; Intellectual Property and Technology
Topics: Christopher Morten

Featured Faculty: Christopher Morten Associate Clinical Professor of Law

April 18, 2023 See generally | University of Pennsylvania Law Review

A Conversation With Professor Chris Morten

Areas of Study: Corporate, Business, and Transactional Law; Intellectual Property and Technology
Topics: Christopher Morten

Featured Faculty: Christopher Morten Associate Clinical Professor of Law

April 04, 2023 Law360

Gilead, DOJ Allowed to Redact Remaining Docs in Patent Row

Areas of Study: Constitutional Law; Intellectual Property and Technology
Topics: Christopher Morten

Featured Faculty: Christopher Morten Associate Clinical Professor of Law